Researchers report in a study, published in Biomolecules and Biomedicine, that lower blood levels of vitamin D are ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 2 study evaluating the efficacy, safety and tolerability of investigational compound NBI-1070770 in adults with major ...

Results of a large study of more than 3 million people show that approximately one third of young adults aged 18-39 experienced anxiety and depression with much lower rates of these disorders in those ...

The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...

A large-scale study of older Australians finds that diets high in ultra-processed food may quietly erode mental wellbeing—boosting depression risk and undermining quality of life, even without ...

Please provide your email address to receive an email when new articles are posted on . Inflammation induced a threefold greater increase in depressed mood and symptoms among older adults with vs.

Please provide your email address to receive an email when new articles are posted on . GLP-1s reduced depression risk vs. DPP-4 inhibitors but not SGLT2 inhibitors. However, both GLP-1s and SGLT2 ...

A brain stimulation treatment improved depression and anxiety symptoms in older adults, a study published last month in Brain Stimulation finds. People with higher levels of symptoms before treatment ...

The study looked at adults with an average age of 19. A new study has found that a 3-week dietary intervention, including cutting down on processed foods, could decrease symptoms of depression in ...

This coastal state tops the list with the lowest number of adults who are diagnosed with depression - and it also comes in ...